Trevi Therapeutics (TRVI) Share-based Compensation Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 81.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.37% |
| Dec 31, 2025 | 47.22% |
| Sep 30, 2025 | 51.22% |
| Jun 30, 2025 | 22.80% |
| Mar 31, 2025 | 67.08% |
| Dec 31, 2024 | 71.72% |
| Sep 30, 2024 | 55.09% |
| Jun 30, 2024 | 112.64% |
| Mar 31, 2024 | 25.09% |
| Dec 31, 2023 | 6.59% |
| Sep 30, 2023 | -6.85% |
| Jun 30, 2023 | 1.92% |
| Mar 31, 2023 | -21.57% |
| Dec 31, 2022 | -7.22% |
| Sep 30, 2022 | 5.37% |
| Jun 30, 2022 | -30.20% |
| Mar 31, 2022 | 2.65% |
| Dec 31, 2021 | 5.88% |
| Sep 30, 2021 | -8.16% |
| Jun 30, 2021 | 26.49% |
| Mar 31, 2021 | -1.64% |
| Dec 31, 2020 | 36.73% |
| Sep 30, 2020 | 58.49% |
| Jun 30, 2020 | 148.52% |
| Mar 31, 2020 | 400.00% |
| Dec 31, 2019 | 101.62% |
| Sep 30, 2019 | 206.61% |
| Jun 30, 2019 | 132.35% |
| Mar 31, 2019 | 65.91% |